PLOD1 and neoplasm: In contrast, PLOD1 overexpression cell line PN03-GSC had a significantly larger tumor volume (Fig. 7b, d) and a notable shorter median survival time than the empty vector control (mean survival: 42.6 ± 3.83 and 21 ± 4.69 days; Fig. 7f).